Bellus Health Company

BELLUS Health is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys.
Technology: Cancer
Industry: PharmTech
Headquarters: Canada
Founded Date: 2010
Employees Number: 11-50
Funding Status: IPO
Acquisitions Number: 2
Total Funding: $44.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
http://twitter.com/BELLUSHealth
Register and Claim Ownership